Intangible assets in general and intellectual capital in particular are important to both society and organizations. It can be a source of competitive advantage for business and stimulate innovation that leads to wealth generation. Technological revolutions, the rise of the knowledge-based...

Entities frequently spend resources or attire debts to purchase, develop, maintain or extend intangible resources like scientific or technical knowledge, design and implementation of new processes and systems, licenses, intellectual property, knowledge on market and brands (including trademarks...

The post-crisis economy brings changes in the functions of the trademarks. The aim of this paper is to evidence the functions of the trademarks as part of the intellectual property and of the intangible in the post-crisis economic frame and to offer an overview of the evolution of these...

In cooperative networks firms appropriate value through bargaining over the economic benefits generated from successful execution of joint tasks and through internalizing the knowledge of partners. Consequently, acquisition and protection of knowledge are the key issues for collaborating...

Questo paper presenta un questionario e una guida pratica per la misurazione del capitale sociale. Il lavoro vuole costituire un vero e proprio manuale rivolto a ricercatori, studenti e docenti, consulenti di impresa e operatori del terzo settore che per qualsiasi ragione, dalla redazione della...

We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e. the increase of the number of new elementary business units and their size growth. We find a power-law relationship...

In 1970 the USA spent 7% of its GNP on healthcare, in 200716%. Whereas the OECD average per capita expenditure on healthcare in 2007 was $2,964, the USA spent $7,290. Yet in that same period, the health of America’s citizens relative to those of other developed countries declined dramatically,...

The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unbalanced panel data for a sample of firms over the period 1989-90 to 2000-01. The study estimates firm-specific productive efficiency growth for domestic firms from frontier production function and...